CERS
Cerus Corporation
NASDAQ · Healthcare · Medical - Devices · US
$2.59
+0.78%Margins
Gross margin
52.0%
EBITDA margin
1.3%
EBIT margin
-0.7%
Net margin
-3.1%
FCF margin
-0.8%
-9.7%
Return on equity
-3.3%
Return on assets
-1.1%
Return on invested capital
1.04x
Asset turnover
$2.4M
Cash from operations
$0.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026